Long-term safety and efficacy of the novel β 3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

To evaluate the long-term safety and efficacy of vibegron 50 mg and 100 mg, a novel β -adrenoreceptor agonist, in Japanese patients with overactive bladder. This was a 1-year, multicenter, open-label, non-controlled study. After a 1-week observation phase, patients were treated with vibegron for 52 ...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of urology 2018-07, Vol.25 (7), p.668-675
Hauptverfasser:	Yoshida, Masaki, Kakizaki, Hidehiro, Takahashi, Satoru, Nagai, Shinji, Kurose, Takafumi
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!